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abstract
 
The skeletal and cardiac muscle dihydropyridine receptors (DHPRs) differ with respect to their rates
 
of channel activation and in the means by which they control Ca
 
2
 
1
 
 release from the sarcoplasmic reticulum (Ad-
 
ams, B.A., and K.G. Beam. 1990. 
 
FASEB J. 
 
4:2809–2816). We have examined the functional properties of skeletal
(SkEIIIK) and cardiac (CEIIIK) DHPRs in which a highly conserved glutamate residue in the pore region of repeat
III was mutated to a positively charged lysine residue. Using expression in dysgenic myotubes, we have character-
ized macroscopic ionic currents, intramembrane gating currents, and intracellular Ca
 
2
 
1
 
 transients attributable to
 
these two mutant DHPRs. CEIIIK supported very small inward Ca
 
2
 
1
 
 currents at a few potentials (from 
 
2
 
20 to 
 
1
 
20
mV) and large outward cesium currents at potentials greater than 
 
1
 
20 mV. SkEIIIK failed to support inward Ca
 
2
 
1
 
ﬂux at any potential. However, large, slowly activating outward cesium currents were observed at all potentials
greater than 
 
1
 
 20 mV. The difference in skeletal and cardiac Ca
 
2
 
1
 
 channel activation kinetics was conserved for
outward currents through CEIIIK and SkEIIIK, even at very depolarized potentials (at 
 
1
 
100 mV; SkEIIIK: 
 
t
 
act
 
 
 
5
 
30.7 
 
6 
 
1.9 ms,
 
 n 
 
5 
 
11; CEIIIK: 
 
t
 
act
 
 
 
5 
 
2.9 
 
6 
 
0.5 ms,
 
 n 
 
5 
 
7). Expression of SkEIIIK in dysgenic myotubes restored
both evoked contractions and depolarization-dependent intracellular Ca
 
2
 
1
 
 transients with parameters of voltage
dependence (V
 
0.5 
 
5 
 
6.5 
 
6
 
 3.2 mV and 
 
k
 
 
 
5 
 
9.3 
 
6
 
 0.7 mV,
 
 n 
 
5 
 
5) similar to those for the wild-type DHPR (Garcia, J.,
T. Tanabe, and K.G. Beam. 1994. 
 
J. Gen. Physiol.
 
 103:125–147). However, CEIIIK-expressing myotubes never con-
tracted and failed to exhibit depolarization-dependent intracellular Ca
 
2
 
1
 
 transients at any potential. Thus, high
Ca
 
2
 
1
 
 permeation is required for cardiac-type excitation–contraction coupling reconstituted in dysgenic myotubes,
but not skeletal-type. The strong rectiﬁcation of the EIIIK channels made it possible to obtain measurements of
gating currents upon repolarization to 
 
2
 
50 mV (Q
 
off
 
) following either brief (20 ms) or long (200 ms) depolarizing
pulses to various test potentials. For SkEIIIK, and not CEIIK, Q
 
off
 
 was signiﬁcantly (
 
P
 
 
 
, 
 
0.001) larger after longer
depolarizations to 
 
1
 
60 mV (121.4 
 
6
 
 2.0%,
 
 n 
 
5 
 
6). The increase in Q
 
off
 
 for long depolarizations exhibited a voltage
dependence similar to that of channel activation. Thus, the increase in Q
 
off
 
 may reﬂect a voltage sensor movement
required for activation of L-type Ca
 
2
 
1
 
 current and suggests that most DHPRs in skeletal muscle undergo this volt-
age-dependent transition.
 
key words:
 
voltage-dependant calcium channels • skeletal muscle • calcium transients • charge movement •
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introduction
 
Skeletal and cardiac muscle dihydropyridine receptors
 
(DHPRs)
 
1
 
 are highly homologous proteins that function
 
both as voltage-gated L-type Ca
 
2
 
1
 
 channels (L-channels)
and as links between sarcolemmal depolarization and
the release of Ca
 
2
 
1
 
 from the sarcoplasmic reticulum
(SR). Nonetheless, there are important differences be-
tween the two proteins. Cardiac L-channels activate
10-fold more rapidly upon depolarization (Tanabe et al.,
1991) and the resulting Ca
 
2
 
1
 
 inﬂux triggers the intracel-
lular release of Ca
 
2
 
1
 
 via ryanodine receptors (RyRs) lo-
cated nearby in the SR (Nabauer et al., 1989). In contrast
to this “cardiac-type” excitation–contraction (EC) cou-
pling, it is generally accepted that activation of RyRs in
skeletal muscle is coupled to conformational changes of
the skeletal DHPR via a mechanical interaction (Chan-
dler et al., 1976; Ríos and Brum, 1987; Tanabe et al.,
1987) that is independent of the entry of extracellular
Ca
 
2
 
1
 
 (Armstrong et al., 1972; Gonzalez-Serratos et al.,
1982). Studies of heterologously expressed Ca
 
2
 
1
 
 chan-
nels in dysgenic myotubes, which lack endogenous skele-
tal L-channels, are consistent with this difference in type
of EC coupling: removal of external Ca
 
2
 
1
 
, or addition of
Cd
 
2
 
1
 
 and La
 
3
 
1
 
 to block Ca
 
2
 
1
 
 entry, abolishes EC cou-
pling in dysgenic myotubes expressing cardiac L-channels
(Tanabe et al., 1990b; Garcia et al., 1994), but not in dys-
 
Portions of this work have been previously published in abstract form
 
(Dirksen, R.T., and K.G. Beam. 1996. 
 
Biophys. J. 
 
70:A146).
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genic myotubes expressing skeletal L-channels (Tanabe
et al., 1988; Garcia
 
 
 
et al., 1994). However, although there
is little doubt that Ca
 
2
 
1
 
-entry–induced Ca
 
2
 
1
 
 release is in-
volved in cardiac EC coupling, recent work suggests that
a mechanical coupling may occur between cardiac
L-channels and RyRs when intracellular cAMP levels are
elevated (Hobai et al., 1997; Santana et al., 1998;
Howlett et al., 1998).
In spite of these distinct functional properties, the se-
lectivity of both skeletal (Almers and McCleskey, 1984)
and cardiac (Hess and Tsien, 1984; Hess et al., 1986)
L-channels for Ca
 
2
 
1
 
 over monovalent cations appears
to involve intrapore binding of Ca
 
2
 
1
 
 with high afﬁnity
(Dang and McCleskey, 1998). Mutational analysis of the
cardiac L-channel indicates that this intrapore Ca
 
2
 
1
 
binding is coordinated by a cage of four conserved
glutamate residues residing in corresponding positions
within each of the pore-lining regions of repeats I–IV of
the 
 
a
 
1
 
 subunit (Kim et al., 1993; Yang et al., 1993). In
fact, a single mutation of the glutamate residue in re-
peat III to a lysine residue is sufﬁcient to alter the car-
diac L-channel such that it exhibits minimal divalent
permeability, large monovalent permeability, and a
 
.
 
1,000-fold decrease in high afﬁnity Ca
 
2
 
1
 
 block of
monovalent currents (Yang
 
 
 
et al., 1993). The effects of
mutating pore region glutamates on the Ca
 
2
 
1
 
 perme-
ability of skeletal L-channels have yet to be elucidated.
Here, we have used expression in dysgenic myotubes
to compare permeation and EC coupling in skeletal and
cardiac L-channels after substitution of lysine for the re-
peat III glutamate. Compared with the wild-type chan-
nel, the mutant cardiac L-channel (CEIIIK) conducted
small inward currents carried by Ca
 
2
 
1
 
 and large outward
currents carried by monovalent cations. The mutant skel-
etal L-channel (SkEIIIK) conducted large outward cur-
rents, but no detectable inward Ca
 
2
 
1
 
 current. As a result
of the greatly reduced Ca
 
2
 
1
 
 entry, CEIIIK lost the ability
of wild-type cardiac L-channels to trigger the release of
SR Ca
 
2
 
1
 
 in dysgenic myotubes. By contrast, SkEIIIK
channels were able, despite the complete loss of Ca
 
2
 
1
 
 en-
try, to trigger the release of SR Ca
 
2
 
1
 
 with a voltage depen-
dence similar to that of the wild type skeletal DHPR.
The production of large outward currents by the
SkEIIIK and CEIIIK channels allowed us to compare
activation rates over a much broader range of voltages
than wild type channels, which can only be compared
for test potentials that are both sufﬁciently positive to
cause activation and sufﬁciently negative to provide a
signiﬁcant driving force for inward Ca
 
2
 
1
 
 current. We
found that the activation rate of both channels was very
weakly voltage dependent and that the activation of
SkEIIIK was 
 
.
 
10-fold slower than that of CEIIIK, even
at 
 
1
 
100 mV.
Skeletal L-channels are unusual in that channel acti-
vation is both slow (
 
t
 
act
 
 
 
. 
 
50 ms; Dirksen and Beam,
 
1995) and weakly voltage dependent, while channel de-
activation is strongly voltage dependent. This behavior
can be accounted for by a linear reaction scheme in
which the rate-limiting transition has an asymmetric
voltage dependence (Dirksen and Beam, 1996). Be-
cause activation is slow, this asymmetric transition
would generate only a very small “ON” gating current
(Q
 
on
 
). However, because deactivation is fast at negative
voltages, repolarization should produce a component
of “OFF” gating current (Q
 
off
 
) with a magnitude that is
dependent on the extent of activation occurring during
a preceding depolarization. An unambiguous test of
this prediction is difﬁcult for wild-type channels since
any apparent increase in Q
 
off
 
 might simply be due to
the presence of incompletely blocked ionic tail current.
However, SkEIIIK, which did not permit inward Ca
 
2
 
1
 
current, provided a powerful tool for testing this pre-
diction. A comparison of Q
 
off
 
 for SkEIIIK after strong
depolarizations of 20 or 200 ms showed that the longer
depolarizations recruited additional gating current,
which increased Q
 
off
 
 by 
 
.
 
20%. The size of the recruitable
SkEIIIK Q
 
off
 
 and the similarity of its voltage dependence
to that of channel conductance indicates that the majority
of skeletal muscle DHPRs not only undergo the voltage-
dependent conformational changes that trigger SR Ca
 
2
 
1
 
release, but also the voltage-dependent transitions that
are required for L-channel opening.
 
methods
 
Preparation of Dysgenic Myotubes
 
Primary cultures of myotubes were prepared from skeletal mus-
cle of newborn dysgenic mice, as described previously (Beam and
Knudson, 1988). All experiments were performed 7–11 d after
the initial plating of myoblasts and were carried out at room tem-
perature (20–22
 
8
 
C). Numerical ﬁgures are presented in the text
and ﬁgures as mean 
 
6
 
 SEM. Data were taken to be statistically
signiﬁcant at
 
 P 
 
, 
 
0.001.
 
Preparation and Expression of cDNAs
 
A glutamate-to-lysine mutation in the repeat III pore region of
the skeletal muscle dihydropyridine receptor was constructed us-
ing PCR. Two initial PCR fragments were produced in separate
but parallel reactions. Each initial fragment was generated by am-
plifying pCAC6 (Tanabe et al., 1988) with an “outer” primer and
a mutating primer. The ﬁnal mutated fragment was obtained by
mixing the two initial PCR products and ampliﬁcation in a third
reaction with the outer primers (Garcia et al., 1997). The compo-
sition of the two mutating primers was, sense: 5
 
9
 
-GTGTCCAC-
CTTTAAAGGATGGCCCCAG-3
 
9
 
 and antisense: 5
 
9
 
-CTGGGGCCAT-
CCTTTAAAGGTGGACAC-3
 
9
 
, where underlining indicates the
mutated region. The composition of the outer primers was, sense
(starting at base 2700): 5
 
9
 
-GTCCGTGAGGAATCAGATCCTTGG-
3
 
9
 
 and antisense (starting at base 4000): 5
 
9
 
-TCCACAGCAGCGT-
GCGCACGCCCT-3
 
9
 
. This mutagenesis strategy not only substi-
tuted a lysine codon (AAA) for the glutamate codon (GAG) in
the pore region of repeat III, but also exchanged phenylalanine
codons (TTT replaced TTC) so as to introduce a novel DraI re- 
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striction site (TTTAAA) that was used to screen clones for the
mutation. Each PCR reaction contained template DNA, 100
pmol of each primer, 100 mM of each deoxyribonuclease triphos-
phate (GIBCO-BRL), 2 U Vent DNA polymerase, 10 ml poly-
merase buffer (103), and sterilized water sufﬁcient to bring the
ﬁnal volume to 100 ml. 35 ampliﬁcation cycles were performed
with a PCR thermal cycler (Perkin-Elmer Corp.); cycle 1, 958C for
4 min, 608C for 2 min, and 728C for 2 min; cycles 2–35, 948C for
1 min, 608C for 1 min, and 728C for 2 min. After the last cycle, an
additional 5-min extension period at 728C was used. This PCR
mutagenesis strategy generated a 1.3-kB mutant fragment that
was subsequently digested with XhoI and HincII to generate a
1.0-kB mutant fragment that was used to replace the correspond-
ing fragment from the 2.7-kb XhoI–SacI fragment of pCAC6 sub-
cloned into pBluescript (Stratagene Inc.). Finally, the 1.7-kB
XhoI–DraIII fragment of the mutant subclone was used to re-
place the corresponding fragment from pCAC6 (Tanabe et al.,
1987) to generate SkEIIIK. The entire 1.0-kB XhoI–HincII re-
gion of SkEIIIK was ultimately sequenced using an ABI 377 auto-
matic sequencer to verify sequence integrity. The cDNA encod-
ing CEIIIK was a generous gift form Dr. William Sather. Both
SkEIIIK and CEIIIK use the mammalian expression vector
pKCRH2 (Tanabe et al., 1988).
Approximately 1 wk after plating, myotubes were microin-
jected (Tanabe et al., 1988; Beam and Franzini-Armstrong, 1997)
into a single nucleus with expression plasmid for either CEIIIK
or SkEIIIK (200–500 ng/ml). Myotubes expressing SkEIIIK were
identiﬁed by contraction in response to extracellular electrical
stimulation (80 V, 10–30 ms). Myotubes expressing CEIIIK never
exhibited electrically evoked contractions and were usually iden-
tiﬁed by coinjecting 20 ng/ml of a cDNA expression plasmid
(Grabner et al., 1998) encoding an enhanced green ﬂuorescent
protein (GFP). In control experiments, coexpression of the GFP
cDNA did not alter the function of expressed L-channels (data
not shown). Coinjection of GFP cDNA was omitted when cells
were to be used for measurement of intracellular Ca21 transients
and the expression of CEIIIK was established on the basis of
large, rapidly activating outward ionic currents.
Measurements of Ionic Currents
The whole cell variant of the patch clamp technique (Hamill et
al., 1981) was used to measure ionic currents, intramembrane
charge movements, and intracellular calcium transients. Pipettes
were fabricated from borosilicate glass and had resistances of
1.8–2.2 MV when ﬁlled with the internal solution. Linear capaci-
tative and leakage currents were determined by averaging the
currents elicited by multiple (usually 10) 20-mV hyperpolarizing
pulses from a holding potential of 280 mV. This control current
was then scaled appropriately and used to correct test currents
for linear components of capacitative and leakage currents. Elec-
tronic compensation was used to reduce the effective series resis-
tance (usually to z1 MV) and the time constant for charging the
linear cell capacitance to ,0.5 ms. Cell capacitance was deter-
mined by integration of the capacity transient resulting from the
control pulse and was used to normalize currents (pA/pF) or
charge movements (nC/mF) obtained from different myotubes.
Ionic currents were ﬁltered at 2 kHz and digitized at 1 kHz. To
measure macroscopic L-current in isolation, a 1-s prepulse to
230 mV followed by a 25-ms repolarization to 250 mV was ad-
ministered before the test pulse (prepulse protocol) to inactivate
T-type Ca21 currents.
The activation phase of L-currents was ﬁtted by the following
exponential function:
(1) It () I¥ 1 t – tact ¤ () exp – [] , =
where I(t) is the current at time t after the depolarization, I` is
the steady state current, and tact is the time constant of activation.
The voltage dependence of SkEIIIK L-channel activation was ob-
tained by tail-current analysis. In brief, myotubes were stepped
for 200 ms to test potentials (V) ranging from 250 to 180 mV;
the instantaneous current (IT) was then measured immediately
after stepping to 140 mV. These data were then normalized to
Imax (the maximal IT) and ﬁtted according to:
(2)
where VG is the potential causing half-maximal activation of
L-type conductance and kG is a slope parameter.
Measurements of Gating Currents
For measurement of intramembrane charge movements, ﬁlter-
ing was at 2 kHz (eight pole Bessel ﬁlter; Frequency Devices Inc.)
and digitization was at 10 kHz. Voltage clamp command pulses
were exponentially rounded with a time constant of 50–300 ms
and the prepulse protocol (see above) was used to reduce the
contribution of gating currents from sodium channels and T-type
Ca21 channels. “OFF” transients of charge movement were mea-
sured for repolarization to 250 mV after test pulses to various
test potentials (250 to 160 mV, in 10-mV increments). The recti-
ﬁcation of the mutant L-channels meant that inﬂux of Ca21 ions
was minimal for CEIIIK and nonexistent for SkEIIIK (see Figs. 1
and 5). However, since some dysgenic myotubes exhibit a small,
endogenous, rapidly activating L-current, residual Ca21 channel
ionic currents were blocked by the addition of 2.0 mM CdCl2 1
0.2 mM LaCl3 to the extracellular recording solution (see Solu-
tions). The integral of the OFF transient for each test potential
(V) was normalized by the maximal value of Qoff (Qmax) and ﬁt-
ted according to:
(3)
where VQ is the potential causing movement of half the maximal
charge, and kQ is a slope parameter.
Measurements of Intracellular Ca21 Transients
Changes in intracellular Ca21 were recorded with Fluo-3, as de-
scribed previously (Garcia et al., 1994; Garcia and Beam, 1994).
In brief, the salt form of the dye was added to the internal solu-
tion. After rupture of the cell membrane and entry into the
whole-cell mode, a waiting period of .5 min was used to allow
the dye to diffuse into the cell interior. A 75W xenon illuminator
and a set of ﬂuorescein ﬁlters were used to excite the dye present
in a small rectangular region of the voltage-clamped myotube. A
computer-controlled shutter was used to block illumination in
the intervals between test pulses. Fluorescence emission was mea-
sured by means of a ﬂuorometer apparatus (Biomedical Instru-
mentation Group, University of Pennsylvania, Philadelphia, PA).
The background ﬂuorescence was measured for each myotube
before membrane rupture and cancelled by analogue subtrac-
tion. Fluorescence data are expressed as DF/Fb, where DF repre-
sents the change in ﬂuorescence from baseline (DF 5 F 2 Fb)
and Fb represents the average myotube ﬂuorescence immediately
before depolarization.
Solutions
For measurements of macroscopic ionic and gating currents, the
internal solution consisted of (mM): 140 Cs-aspartate, 10 Cs2-EGTA,
5 MgCl2, and 10 HEPES, pH 7.40 with CsOH. For the measure-
IT V ()Imax ¤ 11 V G V – () kG ¤ [] exp + {} , ¤ =
QQ max ¤ 11 V Q V – () kQ ¤ [] exp + {} , ¤ =396 Role of Ca21 Permeation in Dihydropyridine Receptor Function
ments of depolarization-induced Ca21 transients (Garcia and
Beam, 1994), the patch pipettes contained an internal solution
composed of (mM): 110 Cs-aspartate, 5 MgATP, 22.8 EGTA, 2.66
CaCl2, 1.2 MgCl2, 0.2 K5 Fluo-3 (Molecular Probes, Inc.), and 10
HEPES, pH 7.40 with CsOH. Ionic currents and intracellular
Ca21 transients were recorded in an external solution containing
(mM): 145 TEA-Cl, 10 CaCl2, 0.003 tetrodotoxin (TTX), and 10
HEPES, pH 7.40 with tetraethylammonium (TEA)-OH. Gating
currents were recorded in an external solution containing
(mM): 145 TEA-Cl, 8 CaCl2, 2 CdCl2, 0.2 LaCl3, 0.003 TTX, and
10 HEPES, pH 7.40 with TEA-OH. The dihydropyridine antago-
nist, (1)-PN 200-110, was kindly provided by Drs. E. Rossi and A.
Lindenmann of Sandoz Ltd. (Basel, Switzerland).
results
A Glutamate-to-Lysine Mutation in the Pore Region of 
Repeat III Alters L-Channel Permeability, but Not 
the Rate of Channel Activation
Fig. 1 shows ionic currents in dysgenic myotubes ex-
pressing SkEIIIK and CEIIIK, the skeletal and cardiac
DHPRs, respectively, in which a highly conserved glu-
tamate residue in the pore region of repeat III was mu-
tated to a positively charged lysine residue. Under the
recording conditions used, the wild-type skeletal and
cardiac L-channels support inward Ca21 currents for
test potentials ranging from about 220 (cardiac) or 0
(skeletal) mV to 160 mV or greater, with the currents
reversing to outward at an extrapolated potential of
more than 170 mV (Tanabe et al., 1988, 1990b; Garcia
and Beam, 1994). As reported previously for expression
in Xenopus oocytes (Yang et al., 1993), CEIIIK channels
expressed in dysgenic myotubes had dramatically al-
tered divalent permeability and mediated inward Ca21
currents for only a few potentials (220 to 110 mV; Fig.
1 A, right). At potentials greater than 120 mV, dys-
genic myotubes expressing CEIIIK exhibited rapidly ac-
tivating outward currents (presumably carried by Cs1,
the predominant intracellular cation). Dysgenic myo-
tubes expressing SkEIIIK L-channels did not exhibit in-
ward currents at any potential, but did give rise to
large, slowly activating outward currents at all poten-
tials greater than 120 mV (Fig. 1 A, left). The outward
currents for both SkEIIIK and CEIIIK were blocked by
a DHP antagonist, conﬁrming that they were produced
by expressed L-channels (at 1100 mV, 1 mM PN 200-
110 reduced the SkEIIIK current by 90.0 6 3.6%, n 5
3, and CEIIIK current by 93.5%, n 5 2).
Fig. 1 B illustrates peak current–voltage relationships
determined from the cells illustrated in Fig. 1 A. Com-
pared with wild-type cardiac channels, the reversal po-
tential for CEIIIK was negatively shifted by z60 mV, in-
dicative of a large change in the permeability of Ca21
relative to Cs1. The negative shift in reversal potential
appeared to have been still larger for SkEIIIK since in-
ward Ca21 currents were not elicited at any test poten-
tial, even though depolarizations .10 mV caused sig-
niﬁcant activation of SkEIIIK channels (see Fig. 2 B).
Furthermore, when outward currents via SkEIIIK were
elicited by strong depolarizations, subsequent repolar-
ization to negative potentials failed to cause inward
ionic tail currents (see below). Thus, the conserved
glutamate in the pore region of repeat III appears to
play a role in controlling Ca21 permeation through the
Figure 1. A glutamate-to-lysine mutation in the pore region of
repeat III of the skeletal (SkEIIIK) and cardiac (CEIIIK) DHPRs
alters channel permeation, but not the rate of channel activation.
(A) Representative whole-cell ionic currents obtained from dys-
genic myotubes expressing either SkEIIIK (left) or CEIIIK (right).
Currents were elicited by 200-ms depolarizations to the indicated
potentials after a prepulse protocol (see methods) used to inacti-
vate T-type Ca21 currents (Adams et al., 1990). Inward currents
were not observed at any potential for the SkEIIIK-expressing myo-
tube and minimal inward currents were observed at a few poten-
tials for the CEIIIK-expressing myotube. The dashed lines repre-
sent zero current levels. (B) Superimposed current–voltage rela-
tionships for the two experiments shown in A. Compared with
their wild-type counterparts (Tanabe et al., 1988, 1990), the poten-
tial at which SkEIIIK and CEIIIK permit outward current ﬂux is
shifted by z60 mV in the hyperpolarized direction. (C) The differ-
ence between the rate of skeletal and cardiac L-current activation
persists in the SkEIIIK and CEIIIK mutants (data from 11 SkEIIIK-
and 7 CEIIIK-expressing myotubes). Note that the rate of skeletal
L-current activation is nearly independent of voltage and remains
slow even at 1100 mV.397 Dirksen and Beam 
skeletal L-channel, which is even more pivotal than its
role in the cardiac L-channel.
Like wild-type skeletal L-channels, the SkEIIIK chan-
nels activated slowly. At test potentials where both pro-
duce appreciable currents (e.g., 160 mV), the SkEIIIK
and native skeletal L-channels both display slow activa-
tion (native: 52.4 6 2.0 ms, n 5 6; SkEIIIK: 40.8 6 1.7
ms, n 5 11). Thus, the identity of the permeating ion
has little effect on activation and the EIIIK channels
provide a convenient tool for extending the compari-
son of skeletal and cardiac activation to more positive
potentials (Fig. 1 C). Even at 1100 mV, activation of
SkEIIIK is more than 10-fold slower than that of CEIIIK
(SkEIIIK: 30.7 6 1.9 ms, n 5 11; CEIIIK: 2.9 6 0.5 ms,
n 5 7). Because activation of the skeletal L-channel is
slow over a broad range of test potentials (120 to 1100
mV), the rate-limiting event for the transition of the
channel from closed to open must be very weakly volt-
age dependent, as we have suggested previously from
single channel analyses (Dirksen and Beam, 1996).
L-Channel Permeability to Ca21 Is Required for Cardiac-type, 
but Not Skeletal-type, EC Coupling
Controversy remains as to whether Ca21 permeation
and/or intrapore Ca21 binding are necessary for the
ability of the cardiac and skeletal L-channels to mediate
EC coupling. We reexamined this issue with the CEIIIK
and SkEIIIK L-channels since they have a profoundly
altered intrapore binding site for Ca21. In initial exper-
iments, contractions were observed in response to ex-
tracellular electrical stimulation (80 V, 10–30 ms) of
dysgenic myotubes injected with cDNA for SkEIIIK but
not in myotubes injected with CEIIIK cDNA. Thus, the
substantial loss of Ca21 permeation caused by the EIIIK
mutation appeared to have eliminated the ability of the
cardiac L-channel, but not the skeletal L-channel, to
mediate EC coupling. However, to determine whether
CEIIIK supports Ca21 release too small to be detected
by contractions, we also used whole-cell voltage clamp-
ing to measure membrane currents and intracellular
Ca21 transients with patch pipettes containing the pen-
tapotassium salt of Fluo-3 (Garcia et al., 1994; Garcia
and Beam, 1994).
Fig. 2 A illustrates Ca21 transients and membrane cur-
rents in dysgenic myotubes expressing either SkEIIIK
(left) or CEIIIK (right). Large Ca21 transients were
present in the myotube expressing SkEIIIK (left), but
not in the one expressing CEIIIK, despite the presence
of large ionic currents (right). Similar results were ob-
tained in ﬁve myotubes expressing SkEIIIK, all of which
displayed depolarization-evoked Ca21 transients, and
ﬁve myotubes expressing CEIIIK, none of which dis-
played Ca21 transients. These data lend strong support
to the notion that Ca21 permeation through skeletal
muscle DHPRs is not required to trigger the release of
Ca21 from the SR (Garcia et al., 1989; Garcia and Beam,
1994). The lack of SR Ca21 release in CEIIIK-expressing
myotubes strongly argues against a Ca21-independent
interaction between the cardiac DHPR and the skeletal
SR Ca21 release channel.
Fig. 2 B plots both normalized conductance (G) and
the amplitude of the Ca21 transient (DF/F) as a function
of test potential for SkEIIIK-expressing myotubes. As in
myotubes expressing the wild-type skeletal DHPR (Gar-
cia and Beam, 1994), the conductance of SkEIIIK
Figure 2. Skeletal-type EC coupling is unaffected, and cardiac-
type EC coupling is abolished, by the repeat III glutamate-to-lysine
mutations in the skeletal and cardiac DHPRs, respectively. (A) Si-
multaneously recorded intracellular Ca21 transients (top) and
ionic currents (bottom) elicited by test pulses to the indicated po-
tentials. The dysgenic myotube expressing SkEIIIK (left) exhibited
depolarization-induced intracellular Ca21 transients at potentials
greater than 210 mV, whereas the CEIIIK-expressing myotube
(right) failed to exhibit Ca21 transients at any potential. The
dashed lines represent basal ﬂuorescence (top) and zero current
(bottom) levels (B) Comparison of the voltage dependence of the
normalized peak intracellular Ca21 transient (d, n 5 5) and peak
conductance (m, n 5 16) obtained from dysgenic myotubes ex-
pressing SkEIIIK L-channels. The smooth solid curves through the
data were obtained by Boltzmann ﬁtting of the averaged data
points. These ﬁts yielded the following values: F V; V0.5 5 16.9 mV
and k 5 10.7 mV and GV; V0.5 5 121.8 mV and k 5 10.5.398 Role of Ca21 Permeation in Dihydropyridine Receptor Function
L-channels is positively shifted by z15 mV compared
with that of Ca21 release. Moreover, the average voltage
dependencies (i.e., averages of Boltzmann ﬁts obtained
from multiple experiments) of G (VG 5 21.6 6 2.3 mV,
kG 5 8.8 6 0.4 mV, n 5 16) and of DF/F (VF 5 6.5 6 3.2
mV, kF 5 9.3 6 0.7 mV, n 5 5) for SkEIIIK L-channels are
also similar to the values reported previously (Garcia et
al., 1994) for dysgenic myotubes expressing the wild-type
skeletal DHPR (VG 5 24.0 mV, kG 5 8.2 mV; VF 5 6.6
mV, kF 5 9.0 mV). The qualitative and quantitative simi-
larity of Ca21 release caused by wild-type and SkEIIIK
L-channels indicates that neither Ca21 permeation nor
high afﬁnity binding of Ca21 within the L-channel pore
play an important role in skeletal-type EC coupling.
An Increase in Qoff Correlates with Slow Activation of
Skeletal L-Current
In comparison with other voltage-gated Ca21 channels,
skeletal L-channels have extremely slow (and relatively
voltage-independent) activation kinetics. Despite this
slow activation, repolarization to negative potentials
causes rapid deactivation, a behavior that can be ex-
plained by a single transition, with an asymmetric volt-
age dependence causing it to be slow in the opening di-
rection and fast in the closing direction (Dirksen and
Beam, 1996). Accordingly, such a transition would pro-
duce only a small Qon but a signiﬁcant Qoff gating current.
We tested this prediction by comparing Qoff gating cur-
rents for SkEIIIK and CEIIIK.
Fig. 3 illustrates representative Qoff gating currents
generated upon repolarization to 250 mV for dysgenic
myotubes expressing either SkEIIIK (left) or CEIIIK
(right). Data were obtained in the presence of 2.0 mM
Cd21 and 0.2 mM La31 (which was required to block
the small inward currents supported by CEIIIK). Qoff is
shown after either brief (20 ms, light traces) or long
(200 ms, dark traces) depolarizing pulses to the indi-
cated potentials. These two pulse durations were used
because 20 ms is long enough to open cardiac L-chan-
nels fully and short enough to only marginally open
skeletal L-channels, whereas 200 ms is sufﬁciently long
to open both cardiac and skeletal L-channels. At poten-
tials less than 110 mV, Qoff was independent of the test
pulse duration for both SkEIIIK and CEIIIK. However,
at potentials that typically activate ionic current (greater
than or equal to 110 mV), Qoff was signiﬁcantly larger
only for SkEIIIK L-channels after the 200-ms test pulses.
The additional Qoff for SkEIIIK L-channels was mani-
fested as a prolongation of the total gating current
rather than simply as an increase in peak of the “OFF”
gating current. Thus, the increase in SkEIIIK Qoff
caused by longer depolarizations is inconsistent with a
contamination from an ionic tail current and presum-
ably arises from an additional amount of gating current
recruited during slow channel activation. In contrast to
SkEIIIK, the magnitude of Qoff for CEIIIK was not in-
creased by the longer test pulse duration. Rather, a
slight decrease in Qoff was found for CEIIIK after the
largest 200-ms depolarizations (to potentials greater
than  130 mV), most likely owing to a small degree of
inactivation during the 200-ms pulses.
Fig. 4 illustrates the voltage dependence of Qoff for
SkEIIIK (A) and CEIIIK (B) after 20-ms test pulses
Figure 3. Long depolarizations recruit additional OFF gating
current for dysgenic myotubes expressing SkEIIIK, but not CEIIIK.
Representative Qoff recordings obtained from dysgenic myotubes
expressing either SkEIIIK (left) or CEIIIK (right). Data were ob-
tained in the presence of 2.0 mM Cd21 and 0.2 mM La31. Expres-
sion of constructs was conﬁrmed in these experiments by the pres-
ence of large outward ionic currents (.40 pA/pF at 1100 mV)
under control conditions (i.e., in the absence of Cd21/La31). Qoff
gating currents were elicited by repolarization to 250 mV after ei-
ther brief (20 ms, light traces) or long (200 ms, dark traces) depo-
larizing pulses to the indicated potentials. The 20-ms pulse was suf-
ﬁcient to fully activate current through CEIIIK channels, but too
brief to signiﬁcantly activate current through SkEIIIK L-channels
(see Fig. 1). The 200-ms pulse fully activated both SkEIIIK and
CEIIIK channels. The dashed lines represent zero current levels. A
signiﬁcant increase in Qoff was only observed at potentials .0 mV
for dysgenic myotubes expressing the SkEIIIK L-channel. A
prepulse protocol (see methods) preceded all test depolarizations
in order to immobilize gating currents due to sodium and T-type
Ca21 channels.399 Dirksen and Beam 
(Q20; d) and 200-ms test pules (Q200; j), and the dif-
ference between the two (Q200–Q20; m). For potentials
.0 mV, Qoff SkEIIIK was larger after 200-ms test pulses
than after 20-ms test pulses. For CEIIIK, no such in-
crease in Qoff occurred after longer duration pulses.
The normalized voltage dependence of Q20, Q200, Q200–
Q20, and channel conductance for the SkEIIIK-express-
ing myotube shown in Fig. 3 are compared in Fig. 4 C.
As reported previously for Qon (Adams et al., 1990; Gar-
cia et al., 1994; Dirksen and Beam, 1995), the voltage
dependence of Qoff after brief depolarizations (Q20)
was leftward shifted and shallower than that of channel
conductance. However, the additional Qoff recruited by
long depolarizations of SkEIIIK L-channels (Q200–Q20;
m) exhibited a voltage dependence nearly identical to
that of channel conductance (s). In a total of four ex-
periments, good agreement was found between the
voltage dependence of conductance (VG 5 24.2 6 6.3
mV and kG 5 7.5 6 1.0 mV) and that of Q200–Q20 (VQ 5
31.4 6 6.7 mV and kQ 5 7.5 6 0.7 mV). Fig. 4 D sum-
marizes the results on maximal Qoff obtained from mul-
tiple experiments. On average, the maximal value of
Qoff for SkEIIIK after 200-ms test pulses was signiﬁ-
cantly greater (121.4 6 2.0%, n 5 6, P , 0.001) than
that after 20-ms test pulses. For CEIIIK, Qoff after 200
ms was not signiﬁcantly different from that after 20 ms
(P . 0.3). Additionally, for both SkEIIIK and CEIIIK,
Qoff after 20 ms had essentially the same magnitude as
Qon (data not shown). Thus, the voltage and time de-
pendence of the Q200–Q20 gating charge, coupled with
its presence only in the SkEIIIK channels, suggests that
this extra gating charge underlies the rate-limiting tran-
sition of slow skeletal channel activation.
Since contamination by inward ionic tail current
would artifactually increase Qoff, it was important to en-
sure that no such contamination was present under our
recording conditions. As one approach, we attempted to
reduce ionic currents by adding Cd21 and La31 to the ex-
ternal bath. At a test potential of 160 mV, these blockers
reduced the outward current by 75.3 6 2.6% (n 5 5) for
SkEIIIK and 82.0 6 2.7 (n 5 5) for CEIIIK. To deter-
mine the effectiveness of this block at more negative po-
tentials, cells were depolarized to 160 mV for 200 ms to
cause maximal activation of channels and then either
maintained at 160 mV or repolarized to varying poten-
tials. As shown for a SkEIIIK-expressing cell in Fig. 5, the
addition of Cd21 and La31 caused a large reduction at
160 mV, where the integrated current was entirely ionic,
but only a small reduction at more negative potentials.
The small effect of the blockers at negative potentials
strengthens the conclusion that SkEIIIK has a very low
permeability to Ca21. Moreover, it seems likely that the
block of this already small Ca21 permeability by Cd21
and La31 should have been sufﬁcient to eliminate any
ionic contamination of the Qoff charge.
discussion
Mutation of Glutamate to Lysine in the Pore Region of Repeat 
III Eliminates Ca21 Permeation through the Skeletal
L-Type Ca21 Channel
In this paper, we have characterized the effects of muta-
tional alteration of Ca21 permeability on the behavior
Figure 4. Long depolarizations increase Qoff in dysgenic express-
ing SkEIIIK, and not CEIIIK, with a voltage dependence that mir-
rors that of channel conductance. (A) Dependence of the abso-
lute magnitude of Qoff for SkEIIIK on voltage during test pulses of
20- (Q20, d) or 200-ms (Q200, j) duration. The voltage depen-
dence of the additional Qoff gating current recruited by the 200-ms
depolarization pulses was determined by subtracting the value of
Q20 from the value of Q200 for each voltage (Q200–Q20, j). (B) De-
pendence of the absolute magnitude of Qoff for CEIIIK on test po-
tential of either 20- (Q20, d) or 200-ms (Q200, j) duration, to-
gether with the voltage dependence of Q200–Q20 (j). Data in A
and B are taken from the same myotubes as those shown in Fig. 3.
(C) Comparisons of the voltage dependence of the normalized
values for Q20, Q200, Q200–Q20, and channel conductance (G) for
SkEIIIK-expressing myotubes. Each data set was ﬁtted by a Boltz-
mann distribution which yielded values of Q20, V0.5 5 220.3 mV
and k 5 11.6 mV; Q200: V0.5 5 216.0 mV and k 5 13.4 mV; Q200–
Q20: V0.5 5 113.0 mV and k 5 8.0 mV; and G: V0.5 5 110.6 mV and
k 5 8.5 mV. Similar results were obtained from a total of six differ-
ent SkEIIIK-expressing myotubes. (D) Effect of depolarization du-
ration on maximal Qoff recorded from dysgenic myotubes express-
ing either SkEIIIK (left, n 5 6) or CEIIIK (right, n 5 3). A signiﬁ-
cant (P , 0.001) increase in maximal Qoff was observed only for
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of skeletal and cardiac L-channels expressed in dys-
genic myotubes. Because there had been no previous
descriptions of mutations affecting Ca21 permeability
of skeletal L-channels, we chose to substitute lysine for
glutamate in the repeat III pore region (EIIIK) since
the corresponding mutation had already been shown to
produce a dramatic alteration in the divalent selectivity
of the cardiac L-channel expressed in Xenopus oocytes
(Yang et al., 1993). Similarly, depolarization of dysgenic
myotubes expressing the CEIIIK channel elicited in-
ward Ca21 currents only for a few test potentials (,20
mV), while stronger depolarizations elicited outward
currents. Thus, introduction of the EIIIK mutation into
the cardiac L-channel caused a large (.60 mV) hyper-
polarizing shift in reversal potential compared with
wild-type cardiac L-channels under the same recording
conditions (Tanabe et al., 1990b; Garcia et al., 1994).
Unlike the CEIIIK channel, which retained a small
Ca21 permeability, the SkEIIIK channel completely lost
permeability to Ca21 as judged by the absence of in-
ward ionic currents either during depolarizing steps
(Fig. 1) or after repolarization to negative potentials
(Figs. 2 and 5). The greater effect of the EIIIK muta-
tion on the selectivity of skeletal L-channels suggests
functional differences between the geometric arrange-
ment of the conserved pore region glutamates in skele-
tal and cardiac L-channels. To test this hypothesis, it
will be necessary to carry out a more systematic analysis
of mutations of the glutamates in each of the four re-
peats of the skeletal DHPR.
Reconstitution of EC Coupling in Dysgenic Myotubes: Ca21 
Permeation and Skeletal and Cardiac EC Coupling
Previous studies have used expression in dysgenic myo-
tubes of skeletal, cardiac, and chimeric DHPRs to dis-
sect mechanisms of EC coupling. With this approach, it
was shown that substitution of skeletal sequence for all
(Tanabe et al., 1990a) or part (Nakai et al., 1999) of the
II–III loop of an otherwise entirely cardiac DHPR was
sufﬁcient to convert the reconstituted EC coupling
from cardiac- to skeletal-type. Subsequently, a number
of laboratories have tested whether peptides derived
from the II–III loop can activate reconstituted RyRs
and/or Ca21 release from SR vesicles. This approach
has revealed that either the entire cardiac II–III loop
(Lu et al., 1994) or peptides corresponding to part of
the loop (El-Hayek and Ikemoto, 1998) are capable of
causing activation of RyRs in these reduced systems.
Furthermore, it has been reported that a skeletal-type
EC coupling mechanism independent of Ca21 inﬂux
can contribute to SR Ca21 release in cardiac muscle
cells, particularly when intracellular cAMP is elevated
(Hobai et al., 1997; Howlett et al., 1998). Thus, it is im-
portant to be certain that the EC coupling mechanism
truly differs when cardiac and skeletal DHPRs are ex-
pressed in dysgenic myotubes. This is particularly im-
portant since earlier assessments of cardiac-type cou-
pling in injected dysgenic myotubes relied, in part, on
the loss of Ca21 release after the addition of Cd21 to the
external medium. However, in addition to blocking en-
try of external Ca21, any Cd21 entering the cells could
have interfered with the measurement of Ca21 by
quenching the Ca21-sensitive dye and/or have directly
blocked RyRs (Xu et al., 1999). We have now shown
that CEIIIK in dysgenic myotubes is unable to trigger
the release of SR Ca21, even in the absence of inorganic
Ca21 channel blockers. Speciﬁcally, myotubes with ro-
bust CEIIIK expression never contracted in response to
strong electrical stimuli and never exhibited depolar-
ization-induced intracellular Ca21 transients. Thus,
large Ca21 ﬂux through cardiac L-channels appears to
be required for reconstitution of cardiac-type SR Ca21
release in dysgenic myotubes. Moreover, the distinct be-
haviors of CEIIIK and SkEIIIK in triggering the release
of SR Ca21 support the use of skeletal/cardiac DHPR
chimeras for identifying regions important for skeletal-
type EC coupling. However, since the RyR isoform in
Figure 5. Lack of inward ionic tail currents under the recording
conditions used to measure Qoff. Representative data collected
from a SkEIIIK-expressing dysgenic myotube obtained under both
ionic (10 mM Ca21, s) and gating current recording conditions (8
mM Ca21, 2.0 mM Cd21, and 0.2 mM La31, d). Cells were depolar-
ized for 200 ms to 160 mV (to fully activate SkEIIIK channels) and
subsequently repolarized to the potentials indicated on the ab-
scissa. Currents during the repolarization period (20 ms) were sub-
sequently integrated and plotted against the repolarization poten-
tial. Outward ionic currents through SkEIIIK (seen as positive inte-
grals at potentials .0 mV) were signiﬁcantly attenuated by Cd21
and La31. At potentials hyperpolarized to 220 mV (inset), nega-
tive integrals were not largely affected by either the Cd21 and La31
solution or by the increase in driving force, indicating a lack of in-
ward ionic currents through SkEIIIK channels. Similar results were
obtained from four separate experiments. 401 Dirksen and Beam 
dysgenic myotubes (i.e., RyR1) differs from that of car-
diac muscle (RyR2), our results do not rule out the pos-
sibility that under some conditions a skeletal-type
mechanism of EC coupling may contribute to SR Ca21
release in native cardiac myocytes.
Occupancy of a metal cation binding site, which is ac-
cessible from the extracellular space, has been re-
ported to be required for the conformational changes
of the skeletal L-channel that result in the activation of
RyR1s (Pizzaro et al., 1989). This site has a binding se-
lectivity and a micromolar Ca21 afﬁnity similar to that
of the site governing ion permeability of L-channels
(Hess and Tsien, 1984; Almers and McCleskey, 1984;
Hess et al., 1986; Dang and McCleskey, 1998), suggest-
ing that this cation-binding site corresponds to the
structures governing Ca21 selectivity of the skeletal
L-channel. Our data demonstrate that SkEIIIK retains
the ability of the wild-type channel to control the release
of SR Ca21 in spite of a complete loss of Ca21 perme-
ability. In fact, the voltage dependence of SR Ca21 re-
lease in dysgenic myotubes expressing SkEIIIK L-chan-
nels was nearly identical to that of the wild-type skeletal
DHPR (Garcia et al., 1994). Thus, the capability of the
skeletal L-channel to mediate EC coupling does not de-
pend on Ca21 permeation. Despite the lack of Ca21 per-
meation, it is possible that a low afﬁnity site in the pore
of SkEIIIK is appreciably occupied by Ca21 under our
experimental conditions (10 mM external Ca21). Alter-
natively, the presence of large outward Cs1 currents,
which should have been blocked by binding of Ca21,
may indicate that there is very little residual binding of
Ca21 within the SkEIIIK pore. If the latter is indeed the
case, it would imply that the metal cation site described
by Pizzaro et al. (1989) does not lie within the pore.
However, a direct evaluation of the contribution of the
pore to the metal binding site involved in EC coupling
will require measurement of SkEIIIK monovalent ionic
currents, intramembrane charge movements, and SR
Ca21 release over a range of extracellular Ca21 concen-
trations.
The results with SkEIIIK raise the obvious question of
what function is played by the slowly activating L-type
Ca21 current in skeletal muscle. Clearly, this current
plays little or no role in contractions elicited by rela-
tively brief depolarizations. Perhaps the Ca21 current
becomes important for contraction only during tetanic
stimulation (Sculptoreanu et al., 1993), or has other
functions such as the regulation of acetylcholine recep-
tor gene expression (Shainberg et al., 1976; Klarsfeld
and Changeux, 1985) or the metabolic stabilization of
acetylcholine receptors (Rotzler et al., 1991). One ap-
proach for identifying these or other roles of the slow
L-type Ca21 current would be to construct mice that
carry a transgene for the SkEIIIK channel and lack the
wild-type skeletal L-channel.
Gating Charge Associated with Slow Activation of 
Skeletal L-Current
As in the case for inward Ca21 currents via wild-type skel-
etal L-channels, outward currents carried by SkEIIIK
L-channels also activate slowly. Moreover, because they
are slow over a broad range of test potentials, the SkEIIIK
L-currents extend previous conclusions that activation
of skeletal L-channels is only very weakly voltage depen-
dent (Fig. 1 C). Nonetheless, steady state activation is
strongly voltage dependent for wild-type (Garcia et al.,
1994) and SkEIIIK channels (Fig. 2 B), with Boltzmann
ﬁts of conductance–voltage (G–V) relationships yielding
a value of k < 8 mV, which corresponds to an effective
valence of approximately three electronic charges. This
effective valence represents z25% of the total gating
charge expected for voltage-gated calcium channels
(Noceti et al., 1996). However, the G–V relationship for
wild-type skeletal DHPRs expressed in dysgenic myo-
tubes is rightward shifted z30 mV with respect to the
Qon–V relationship (Adams et al., 1990). Thus, nearly all
of the measured gating current moves at voltages more
negative than those over which the conductance in-
crease occurs. One possibility consistent with this result
is that there may be two separate populations of DHPRs
in skeletal muscle: one population related to EC cou-
pling that produces nearly all of the measured charge
movement and a second population that functions as
Ca21 channels and produces negligible gating current.
An alternative possibility is that all of the DHPRs may
undergo gating transitions that lead to the activation of
L-channels, but that one of these transitions moves ap-
preciable charge (e.g., approximately three electronic
charges) too slowly to be detected during brief depolar-
izations (as is typically used in measurements of Qon).
A simple linear kinetic scheme consistent with the
second possibility above, as well as with measurements
of unitary currents through skeletal L-channels (Dirk-
sen and Beam, 1996) is shown in Scheme I. 
In this model, rapid gating currents are produced by
closed–closed transitions, which for simplicity are indi-
cated by the single C0–C1 transition. These gating tran-
sitions could be important for triggering release of
Ca21, since Ca21 release has a voltage dependence
much closer to that of Qon than does L-channel con-
ductance (Garcia et al., 1994). In the model, the rate
constant b must be large because single channel open
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times are brief (z1 ms; Dirksen and Beam, 1996), and
slow activation of L-type conductance is a consequence
of the C1–C2 transition, with forward and reverse rate
constants d and e, respectively. The rate constant d must
be small and not strongly voltage dependent because
activation remains slow for SkEIIIK even at 1100 mV.
By contrast, the rate constant e must be strongly voltage
dependent such that it is small at the depolarized po-
tentials causing activation of current and large at nega-
tive voltages (e.g., 250 mV) causing deactivation. This
behavior, which suggests that the energy barrier sepa-
rating C1 and C2 is asymmetrically located with respect
to the transmembrane potential drop, is required be-
cause activation is slow, whereas deactivation is rapid
(Dirksen and Beam, 1996). An explicit prediction of
this reaction scheme is that the component of gating
charge that is associated with the C1–C2 transition
would move slowly outward during depolarization and
rapidly inward upon repolarization. The rectiﬁcation of
SkEIIIK under our experimental conditions (TEA1 and
Ca21 as external cations) allowed a clear test of this pre-
diction and revealed that additional Qoff is recruited by
depolarizations that are sufﬁcient to activate ionic cur-
rent. The voltage dependence of this additional charge
is nearly identical to that of channel conductance, con-
sistent with the hypothesis that this charge moves dur-
ing a transition required for channel activation.
Based on chimeras of the skeletal and cardiac
L-channels, it was shown that the sequence of IS3 and
the IS3–IS4 linker determines whether activation is fast
or slow (Nakai et al., 1994), perhaps by governing the
rate of movement of the nearby voltage-sensing IS4 seg-
ment. Thus, it is tempting to speculate that repeat I
produces the additional Qoff that we found to be re-
cruited by long depolarizations. If each of the four re-
peats contributed equivalent gating charge, then the
long depolarizations should have caused a 33% (1/4 4
3/4) increase in Qoff, somewhat larger than the ob-
served value of z20%. However, it seems likely that our
measurement of the difference in Qoff after 20- and
200-ms depolarizations underestimated the gating
charge associated closely with channel activation, be-
cause 20-ms depolarizations cause some activation (see
Figs. 1 A and 2 A). In any case, the size of the re-
cruitable Qoff suggests that all DHPRs undergo the con-
formational change required for activation of L-type
conductance. Neutralization of basic residues in the S4
segments (Garcia et al., 1997) would provide one test
for the idea that this recruitable charge represents
movements within IS4.
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